|

NEO100 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Neonc Technologies, Inc.1

Indications

  • Residual, Progressive or Recurrent Grade II or III Meningioma1
  • Cancer1

Los Angeles, California1 trial

NEO100 and High-Grade Meningioma

University of Southern California

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.